These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30014922)

  • 1. Tetrahydroindolocarbazoles (THICZs) as new class of urokinase (uPA) inhibitors: Synthesis, anticancer evaluation, DNA-damage determination, and molecular modelling study.
    El-Sharief MAMS; El-Naggar MH; Ahmed EM; El-Messery SM; Mahmoud AE; Ali MM; Salem LM; Mahrous KF; El Sayed MT
    Bioorg Chem; 2018 Oct; 80():545-554. PubMed ID: 30014922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards breast cancer targeting: Synthesis of tetrahydroindolocarbazoles, antibreast cancer evaluation, uPA inhibition, molecular genetic and molecular modelling studies.
    Ahmed EM; Sarhan AE; El-Naggar DH; Khattab RR; El-Naggar M; El-Messery SM; Hassan GS; Mounier MM; Mahmoud K; Ali NI; Mahrous KF; Ali MM; El Sayed MT
    Bioorg Chem; 2019 Dec; 93():103332. PubMed ID: 31593885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annulated pyrazole derivatives as a novel class of urokinase (uPA) inhibitors: Green synthesis, anticancer activity, DNA-damage evaluation, and molecular modelling study.
    Farag PS; AboulMagd AM; Hemdan MM; Hassaballah AI
    Bioorg Chem; 2023 Jan; 130():106231. PubMed ID: 36335649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA).
    Matthews H; Ranson M; Tyndall JD; Kelso MJ
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6760-6. PubMed ID: 21978672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.
    Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM
    Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
    Zhu G; Conner SE; Zhou X; Shih C; Li T; Anderson BD; Brooks HB; Campbell RM; Considine E; Dempsey JA; Faul MM; Ogg C; Patel B; Schultz RM; Spencer CD; Teicher B; Watkins SA
    J Med Chem; 2003 May; 46(11):2027-30. PubMed ID: 12747775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytostatic evaluation and structure activity relationships of novel bis-indolylmethanes and their corresponding tetrahydroindolocarbazoles.
    El Sayed MT; Ahmed KM; Mahmoud K; Hilgeroth A
    Eur J Med Chem; 2015 Jan; 90():845-59. PubMed ID: 25528338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.
    Galal SA; Abdelsamie AS; Shouman SA; Attia YM; Ali HI; Tabll A; El-Shenawy R; El Abd YS; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Girgis AS; El-Diwani HI
    Eur J Med Chem; 2017 Jul; 134():392-405. PubMed ID: 28433679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzamide and Benzamidine Compounds as New Inhibitors of Urokinasetype Plasminogen Activators.
    Kuş C; Özer E; Korkmaz Y; Yurtcu E; Dağalp R
    Mini Rev Med Chem; 2018; 18(20):1753-1758. PubMed ID: 30112993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents.
    Pierce LT; Cahill MM; Winfield HJ; McCarthy FO
    Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 3-(9H-carbazol-9-yl)-2-(1,3-dioxoisoindolin-2-yl)propanoic acids as promising DNMT1 inhibitors.
    Liu J; Ruan M; Liu Y; Hong X; Zhang L; Zhang Q
    Eur J Med Chem; 2024 Aug; 274():116538. PubMed ID: 38823264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives.
    Moreau P; Gaillard N; Marminon C; Anizon F; Dias N; Baldeyrou B; Bailly C; Pierré A; Hickman J; Pfeiffer B; Renard P; Prudhomme M
    Bioorg Med Chem; 2003 Nov; 11(23):4871-9. PubMed ID: 14604648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic urokinase inhibitors as potential antitumor drugs.
    Steinmetzer T
    IDrugs; 2003 Feb; 6(2):138-46. PubMed ID: 12789617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
    Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
    Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents.
    Routier S; Mérour JY; Dias N; Lansiaux A; Bailly C; Lozach O; Meijer L
    J Med Chem; 2006 Jan; 49(2):789-99. PubMed ID: 16420063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative.
    Shamroukh AH; El-Shahat M; Drabowicz J; Ali MM; Rashad AE; Ali HS
    Eur J Med Chem; 2013 Nov; 69():521-6. PubMed ID: 24095746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Anti-Cancer and Anti-Migratory Evaluation of 3,6-Dibromocarbazole and 5-Bromoindole Derivatives.
    Butler-Fernández KM; Ramos Z; Francis-Malavé AM; Bloom J; Dharmawardhane S; Hernández E
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31344865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C; Sirchia R; Pupello D
    J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
    Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
    Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
    Wang YQ; Li XH; He Q; Chen Y; Xie YY; Ding J; Miao ZH; Yang CH
    Eur J Med Chem; 2011 Dec; 46(12):5878-84. PubMed ID: 22000922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.